{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:06:42Z","timestamp":1779311202663,"version":"3.51.4"},"reference-count":125,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,1]],"date-time":"2027-04-01T00:00:00Z","timestamp":1806537600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK125586"],"award-info":[{"award-number":["R01DK125586"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK135942"],"award-info":[{"award-number":["R01DK135942"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.mayocp.2025.12.001","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:23:33Z","timestamp":1770985413000},"page":"648-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Emerging Cardiovascular Risk Factors in Chronic Kidney Disease in the \u201cOmics\u201d Era: Gut and Beyond"],"prefix":"10.1016","volume":"101","author":[{"given":"Keiichi","family":"Sumida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocp.2025.12.001_bib1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication\u2014worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.mayocp.2025.12.001_bib2","article-title":"2024 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States","year":"2024","journal-title":"National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases"},{"issue":"13","key":"10.1016\/j.mayocp.2025.12.001_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.mayocp.2025.12.001_bib4","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2025.12.001_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41581-022-00616-6","article-title":"Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease","volume":"18","author":"Matsushita","year":"2022","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.semnephrol.2016.05.006","article-title":"Cardiovascular disease consequences of CKD","volume":"36","author":"Go","year":"2016","journal-title":"Semin Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib7","doi-asserted-by":"crossref","first-page":"F938","DOI":"10.1152\/ajprenal.00256.2017","article-title":"Inflammation and premature aging in advanced chronic kidney disease","volume":"313","author":"Kooman","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.mayocp.2025.12.001_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1556\/2060.106.2019.19","article-title":"The gut-kidney-heart axis in chronic kidney disease","volume":"106","author":"Sumida","year":"2019","journal-title":"Physiol Int"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.mayocp.2025.12.001_bib10","article-title":"Scientists bust myth that our bodies have more bacteria than human cells","author":"Abbott","year":"2016","journal-title":"Nature"},{"issue":"7164","key":"10.1016\/j.mayocp.2025.12.001_bib11","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.mayocp.2025.12.001_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"O'Hara","year":"2006","journal-title":"EMBO Rep"},{"issue":"6086","key":"10.1016\/j.mayocp.2025.12.001_bib13","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","article-title":"Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome","volume":"3","author":"Turnbaugh","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"7402","key":"10.1016\/j.mayocp.2025.12.001_bib15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"issue":"7402","key":"10.1016\/j.mayocp.2025.12.001_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","article-title":"Structure, function and diversity of the healthy human microbiome","volume":"486","year":"2012","journal-title":"Nature"},{"issue":"5728","key":"10.1016\/j.mayocp.2025.12.001_bib17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mayocp.2025.12.001_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2015.09.027","article-title":"Role of the gut microbiome in uremia: a potential therapeutic target","volume":"67","author":"Ramezani","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"14","key":"10.1016\/j.mayocp.2025.12.001_bib19","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1101\/gad.284091.116","article-title":"Metabolites: messengers between the microbiota and the immune system","volume":"30","author":"Levy","year":"2016","journal-title":"Genes Dev"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2025.12.001_bib20","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1097\/00008469-199703001-00009","article-title":"Intestinal flora and endogenous vitamin synthesis","volume":"6","author":"Hill","year":"1997","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.mayocp.2025.12.001_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.nutr.22.011602.092259","article-title":"How host-microbial interactions shape the nutrient environment of the mammalian intestine","volume":"22","author":"Hooper","year":"2002","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"10.1016\/j.mayocp.2025.12.001_bib22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1574-6976.1998.tb00382.x","article-title":"Biotransformation of monoterpenes, bile acids, and other isoprenoids in anaerobic ecosystems","volume":"22","author":"Hylemon","year":"1998","journal-title":"FEMS Microbiol Rev"},{"issue":"3","key":"10.1016\/j.mayocp.2025.12.001_bib23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.mayocp.2025.12.001_bib24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ndt\/gfv095","article-title":"Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment","volume":"31","author":"Vaziri","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease","volume":"19","author":"Fan","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mayocp.2025.12.001_bib26","article-title":"Dysbiosis of the gut microbiota in disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb Ecol Health Dis"},{"issue":"3","key":"10.1016\/j.mayocp.2025.12.001_bib27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/toxins14030176","article-title":"Microbiome in chronic kidney disease (CKD): an omics perspective","volume":"14","author":"Lohia","year":"2022","journal-title":"Toxins (Basel)"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib28","first-page":"349","article-title":"Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis","volume":"74","author":"Hida","year":"1996","journal-title":"Nephron"},{"issue":"8","key":"10.1016\/j.mayocp.2025.12.001_bib29","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1440-1797.2012.01647.x","article-title":"Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients","volume":"17","author":"Wang","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1681\/ASN.0000000000000071","article-title":"Gut dysbiosis in experimental kidney disease: a meta-analysis of rodent repository data","volume":"34","author":"Randall","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"6S","key":"10.1016\/j.mayocp.2025.12.001_bib31","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1053\/j.jrn.2022.12.003","article-title":"New insights into dietary approaches to potassium management in chronic kidney disease","volume":"33","author":"Sumida","year":"2023","journal-title":"J Ren Nutr"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2023.151408","article-title":"Gut microbiota\u2013targeted interventions in the management of chronic kidney disease","volume":"43","author":"Sumida","year":"2023","journal-title":"Semin Nephrol"},{"issue":"7","key":"10.1016\/j.mayocp.2025.12.001_bib33","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/toxins10070298","article-title":"Intestinal barrier function in chronic kidney disease","volume":"10","author":"Meijers","year":"2018","journal-title":"Toxins (Basel)"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MNH.0000000000000661","article-title":"Microbiome modulation as a novel therapeutic approach in chronic kidney disease","volume":"30","author":"Sumida","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00240-003-0381-7","article-title":"Bacterial translocation in experimental uremia","volume":"32","author":"de Almeida Duarte","year":"2004","journal-title":"Urol Res"},{"issue":"11","key":"10.1016\/j.mayocp.2025.12.001_bib36","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s10620-012-2242-0","article-title":"Gut bacterial translocation contributes to microinflammation in experimental uremia","volume":"57","author":"Wang","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.mayocp.2025.12.001_bib37","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10620-014-3202-7","article-title":"Gut bacterial translocation may aggravate microinflammation in hemodialysis patients","volume":"59","author":"Shi","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/sur.2017.264","article-title":"Pathogen- and danger-associated molecular patterns and the cytokine response in sepsis","volume":"19","author":"Rajaee","year":"2018","journal-title":"Surg Infect (Larchmt)"},{"issue":"8","key":"10.1016\/j.mayocp.2025.12.001_bib39","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.4049\/jimmunol.158.8.3635","article-title":"Contribution of CpG motifs to the immunogenicity of DNA vaccines","volume":"158","author":"Klinman","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.mayocp.2025.12.001_bib40","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CpG motifs in bacterial DNA and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"10.1016\/j.mayocp.2025.12.001_bib41","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1093\/ndt\/gfm414","article-title":"Bacterial DNA prolongs the survival of inflamed mononuclear cells in haemodialysis patients","volume":"22","author":"Navarro","year":"2007","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib42","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1210\/er.2019-00002","article-title":"Inflammation in the pathophysiology and therapy of cardiometabolic disease","volume":"40","author":"Donath","year":"2019","journal-title":"Endoc Rev"},{"issue":"5","key":"10.1016\/j.mayocp.2025.12.001_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125162","article-title":"Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients","volume":"10","author":"Szeto","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.mayocp.2025.12.001_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.892232","article-title":"Circulating microbiota in cardiometabolic disease","volume":"12","author":"Sumida","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"10.1016\/j.mayocp.2025.12.001_bib45","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.ekir.2021.07.023","article-title":"Circulating microbial signatures and cardiovascular death in patients with ESRD","volume":"6","author":"Sumida","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"10S","key":"10.1016\/j.mayocp.2025.12.001_bib46","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2024a8yyyt52","article-title":"Circulating Mycobiota and Mortality among Patients Undergoing Hemodialysis: FR-PO360","volume":"35","author":"Sumida","year":"2024","journal-title":"Journal of the American Society of Nephrology"},{"issue":"23","key":"10.1016\/j.mayocp.2025.12.001_bib47","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2016.5951","article-title":"Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease","volume":"315","author":"Ganz","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.mayocp.2025.12.001_bib48","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41591-019-0665-2","article-title":"Plasma protein patterns as comprehensive indicators of health","volume":"25","author":"Williams","year":"2019","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.mayocp.2025.12.001_bib49","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.117.028213","article-title":"Improving assessment of drug safety through proteomics: early detection and mechanistic characterization of the unforeseen harmful effects of torcetrapib","volume":"137","author":"Williams","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.mayocp.2025.12.001_bib50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrd3141","article-title":"Aptamers as therapeutics","volume":"9","author":"Keefe","year":"2010","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"10.1016\/j.mayocp.2025.12.001_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100714","article-title":"Circulating proteins and mortality in CKD: a proteomics study of the AASK and ARIC cohorts","volume":"5","author":"Srialluri","year":"2023","journal-title":"Kidney Med"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib52","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s40620-018-0556-5","article-title":"Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease","volume":"32","author":"Feldreich","year":"2019","journal-title":"J Nephrol"},{"issue":"23","key":"10.1016\/j.mayocp.2025.12.001_bib53","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/eurheartj\/ehad115","article-title":"Proteomic cardiovascular risk assessment in chronic kidney disease","volume":"44","author":"Deo","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1681\/ASN.0000000502","article-title":"Proteomic assessment of the risk of secondary cardiovascular events among individuals with CKD","volume":"36","author":"Deo","year":"2025","journal-title":"J Am Soc Nephrol"},{"issue":"30","key":"10.1016\/j.mayocp.2025.12.001_bib55","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/eurheartj\/ehae288","article-title":"Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification","volume":"45","author":"Dubin","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mayocp.2025.12.001_bib56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2013.03.033","article-title":"Metabolomics in chronic kidney disease","volume":"422","author":"Zhao","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.mayocp.2025.12.001_bib57","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrcardio.2011.138","article-title":"Metabolomics as a tool for cardiac research","volume":"8","author":"Griffin","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"10.1016\/j.mayocp.2025.12.001_bib58","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.117.311002","article-title":"Cardiovascular metabolomics","volume":"122","author":"McGarrah","year":"2018","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.mayocp.2025.12.001_bib59","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005705","article-title":"Comprehensive metabolomic profiling and incident cardiovascular disease: a systematic review","volume":"6","author":"Ruiz-Canela","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.mayocp.2025.12.001_bib60","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","article-title":"Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts","volume":"131","author":"Wurtz","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2025.12.001_bib61","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1681\/ASN.2009111132","article-title":"Metabolite profiling identifies markers of uremia","volume":"21","author":"Rhee","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.mayocp.2025.12.001_bib62","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/hr.2010.113","article-title":"Metabolomic profiling of uremic solutes in CKD patients","volume":"33","author":"Toyohara","year":"2010","journal-title":"Hypertens Res"},{"issue":"8","key":"10.1016\/j.mayocp.2025.12.001_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071199","article-title":"Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients","volume":"8","author":"Mutsaers","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mayocp.2025.12.001_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000542","article-title":"A plasma long-chain acylcarnitine predicts cardiovascular mortality in incident dialysis patients","volume":"2","author":"Kalim","year":"2013","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.mayocp.2025.12.001_bib65","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1681\/ASN.2015121302","article-title":"Microbiota-derived phenylacetylglutamine associates with overall mortality and cardiovascular disease in patients with CKD","volume":"27","author":"Poesen","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.mayocp.2025.12.001_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126048","article-title":"Free levels of selected organic solutes and cardiovascular morbidity and mortality in hemodialysis patients: results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators","volume":"10","author":"Shafi","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mayocp.2025.12.001_bib67","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.kint.2016.01.014","article-title":"Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events","volume":"89","author":"Kim","year":"2016","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib68","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.kint.2017.03.053","article-title":"The role of trimethylamine N-oxide as a mediator of cardiovascular complications in chronic kidney disease","volume":"92","author":"Tomlinson","year":"2017","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib69","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005022","article-title":"Indoxyl sulfate: a novel cardiovascular risk factor in chronic kidney disease","volume":"6","author":"Hung","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.mayocp.2025.12.001_bib70","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41569-020-00477-1","article-title":"Systems biology in cardiovascular disease: a multiomics approach","volume":"18","author":"Joshi","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pcad.2012.06.003","article-title":"Transcriptomic biomarkers of cardiovascular disease","volume":"55","author":"Pedrotty","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.mayocp.2025.12.001_bib72","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/CIRCRESAHA.117.310910","article-title":"Advances in transcriptomics: investigating cardiovascular disease at unprecedented resolution","volume":"122","author":"Wirka","year":"2018","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.mayocp.2025.12.001_bib73","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrneph.2016.51","article-title":"Long noncoding RNAs in kidney and cardiovascular diseases","volume":"12","author":"Lorenzen","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.mayocp.2025.12.001_bib74","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7829174","article-title":"The discovery of novel genomic, transcriptomic, and proteomic biomarkers in cardiovascular and peripheral vascular disease: the state of the art","volume":"2016","author":"de Franciscis","year":"2016","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.mayocp.2025.12.001_bib75","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.molmed.2020.02.001","article-title":"Noncoding RNAs versus protein biomarkers in cardiovascular disease","volume":"26","author":"Schulte","year":"2020","journal-title":"Trends Mol Med"},{"issue":"19","key":"10.1016\/j.mayocp.2025.12.001_bib76","doi-asserted-by":"crossref","first-page":"8665","DOI":"10.7150\/thno.46123","article-title":"Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids","volume":"10","author":"de Gonzalo\u2013Calvo","year":"2020","journal-title":"Theranostics"},{"issue":"15","key":"10.1016\/j.mayocp.2025.12.001_bib77","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.3390\/jcm12155010","article-title":"Circulating microRNA profiles for premature cardiovascular death in patients with kidney failure with replacement therapy","volume":"12","author":"Kuscu","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib78","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/HYPERTENSIONAHA.118.12261","article-title":"Circulating long noncoding RNA LIPCAR predicts heart failure outcomes in patients without chronic kidney disease","volume":"73","author":"Santer","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.mayocp.2025.12.001_bib79","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijcard.2018.08.013","article-title":"Circulating long noncoding RNA DKFZP434I0714 predicts adverse cardiovascular outcomes in patients with end-stage renal disease","volume":"277","author":"Lai","year":"2019","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.mayocp.2025.12.001_bib80","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/ATVBAHA.117.309566","article-title":"Circulating microRNA-125b predicts the presence and progression of uremic vascular calcification","volume":"37","author":"Chao","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.mayocp.2025.12.001_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103079","article-title":"Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients","volume":"9","author":"Wen","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.mayocp.2025.12.001_bib82","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1681\/ASN.2016111215","article-title":"MicroRNA-92a mediates endothelial dysfunction in CKD","volume":"28","author":"Shang","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbadis.2013.10.005","article-title":"Possible involvement of microRNAs in vascular damage in experimental chronic kidney disease","volume":"1842","author":"Taibi","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.mayocp.2025.12.001_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064558","article-title":"Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD)","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4161\/epi.1.2.2762","article-title":"Epigenetics: a historical overview","volume":"1","author":"Holliday","year":"2006","journal-title":"Epigenetics"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35049533","article-title":"DNA methylation in health and disease","volume":"1","author":"Robertson","year":"2000","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.mayocp.2025.12.001_bib87","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymeth.2020.06.022","article-title":"Modern epigenetics methods in biological research","volume":"187","author":"Li","year":"2021","journal-title":"Methods"},{"key":"10.1016\/j.mayocp.2025.12.001_bib88","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2017.05.022","article-title":"Association between DNA methylation and coronary heart disease or other atherosclerotic events: a systematic review","volume":"263","author":"Fernandez-Sanles","year":"2017","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib89","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCRESAHA.115.305206","article-title":"The role of DNA methylation in cardiovascular risk and disease: methodological aspects, study design, and data analysis for epidemiological studies","volume":"118","author":"Zhong","year":"2016","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib90","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13148-023-01468-y","article-title":"DNA methylation and cardiovascular disease in humans: a systematic review and database of known CpG methylation sites","volume":"15","author":"Krolevets","year":"2023","journal-title":"Clin Epigenetics"},{"issue":"8","key":"10.1016\/j.mayocp.2025.12.001_bib91","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015299","article-title":"Epigenomic assessment of cardiovascular disease risk and interactions with traditional risk metrics","volume":"9","author":"Westerman","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13148-022-01341-4","article-title":"A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events","volume":"14","author":"Cappozzo","year":"2022","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib93","article-title":"Epigenetic contributions to clinical risk prediction of cardiovascular disease","volume":"17","author":"Chybowska","year":"2024","journal-title":"Circ Genom Precis Medi"},{"issue":"6","key":"10.1016\/j.mayocp.2025.12.001_bib94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCGENETICS.112.963207","article-title":"SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes","volume":"5","author":"Zawada","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib95","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2214394","article-title":"Association of DNA methylation signatures with premature ageing and cardiovascular death in patients with end-stage kidney disease: a pilot epigenome-wide association study","volume":"18","author":"Sumida","year":"2023","journal-title":"Epigenetics"},{"issue":"7","key":"10.1016\/j.mayocp.2025.12.001_bib96","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ni.2341","article-title":"F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation","volume":"13","author":"Zhao","year":"2012","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.mayocp.2025.12.001_bib97","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1096\/fj.12-223099","article-title":"SCF E3 ligase F-box protein complex SCFFBXL19 regulates cell migration by mediating Rac1 ubiquitination and degradation","volume":"27","author":"Zhao","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.mayocp.2025.12.001_bib98","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-13-76","article-title":"F-box protein complex FBXL19 regulates TGF\u03b21-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation","volume":"13","author":"Dong","year":"2014","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib99","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43586-021-00056-9","article-title":"Genome-wide association studies","volume":"1","author":"Uffelmann","year":"2021","journal-title":"Nat Rev Methods Primers"},{"issue":"7367","key":"10.1016\/j.mayocp.2025.12.001_bib100","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"Ehret","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib101","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ajhg.2007.11.001","article-title":"Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia","volume":"82","author":"Wallace","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.mayocp.2025.12.001_bib102","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1000 genomes\u2013based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.mayocp.2025.12.001_bib103","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jacc.2013.01.103","article-title":"Candidate gene association study of coronary artery calcification in chronic kidney disease: findings from the CRIC study (Chronic Renal Insufficiency Cohort)","volume":"62","author":"Ferguson","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2025.12.001_bib104","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","article-title":"A catalog of genetic loci associated with kidney function from analyses of a million individuals","volume":"51","author":"Wuttke","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.mayocp.2025.12.001_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.592461","article-title":"Improved detection of potentially pleiotropic genes in coronary artery disease and chronic kidney disease using GWAS summary statistics","volume":"11","author":"Chen","year":"2020","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.mayocp.2025.12.001_bib106","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","article-title":"Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease","volume":"17","author":"Jaiswal","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"7513","key":"10.1016\/j.mayocp.2025.12.001_bib107","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature13619","article-title":"Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells","volume":"512","author":"Flach","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib108","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.stem.2018.01.011","article-title":"Clonal hematopoiesis and evolution to hematopoietic malignancies","volume":"22","author":"Bowman","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"26","key":"10.1016\/j.mayocp.2025.12.001_bib109","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.mayocp.2025.12.001_bib110","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.mayocp.2025.12.001_bib111","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib112","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jacc.2019.06.007","article-title":"Clonal hematopoiesis: crossroads of aging, cardiovascular disease, and cancer: JACC review topic of the week","volume":"74","author":"Libby","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2025.12.001_bib113","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib114","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"6327","key":"10.1016\/j.mayocp.2025.12.001_bib115","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.mayocp.2025.12.001_bib116","first-page":"1801","article-title":"Clonal hematopoiesis of indeterminate potential and cardiovascular risk in patients with chronic kidney disease without previous cardiac pathology","volume":"13","author":"Kislikova","year":"2023","journal-title":"Life (Basel)"},{"issue":"11","key":"10.1016\/j.mayocp.2025.12.001_bib117","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41568-022-00502-0","article-title":"Big data in basic and translational cancer research","volume":"22","author":"Jiang","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"suppl 2","key":"10.1016\/j.mayocp.2025.12.001_bib118","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12859-015-0857-9","article-title":"Methods for the integration of multi-omics data: mathematical aspects","volume":"17","author":"Bersanelli","year":"2016","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"10.1016\/j.mayocp.2025.12.001_bib119","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrcardio.2017.78","article-title":"Mendelian randomization in cardiometabolic disease: challenges in evaluating causality","volume":"14","author":"Holmes","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2025.12.001_bib120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12920-022-01190-3","article-title":"ECNano: a cost-effective workflow for target enrichment sequencing and accurate variant calling on 4800 clinically significant genes using a single MinION flowcell","volume":"15","author":"Leung","year":"2022","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.mayocp.2025.12.001_bib121","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41587-020-00746-x","article-title":"Readfish enables targeted nanopore sequencing of gigabase-sized genomes","volume":"39","author":"Payne","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.mayocp.2025.12.001_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.100971","article-title":"Precise and cost-effective nanopore sequencing for post-GWAS fine-mapping and causal variant identification","volume":"23","author":"Magdy","year":"2020","journal-title":"iScience"},{"issue":"W1","key":"10.1016\/j.mayocp.2025.12.001_bib123","doi-asserted-by":"crossref","first-page":"W537","DOI":"10.1093\/nar\/gky379","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update","volume":"46","author":"Afgan","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.mayocp.2025.12.001_bib124","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"6190","key":"10.1016\/j.mayocp.2025.12.001_bib125","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1251546","article-title":"Research capacity. Enabling the genomic revolution in Africa","volume":"344","author":"Rotimi","year":"2014","journal-title":"Science"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962507627X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962507627X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:12:50Z","timestamp":1779307970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561962507627X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":125,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S002561962507627X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.12.001","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Cardiovascular Risk Factors in Chronic Kidney Disease in the \u201cOmics\u201d Era: Gut and Beyond","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}